DrugPatentWatch Database Preview
Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
» See Plans and Pricing
OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
| Docket | Start Trial | Date Filed | 2014-02-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-09-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | Referred To | Karen M. Williams | |
| Patents | 7,053,092; 8,017,615; 8,580,796; 8,642,600; 8,642,760; 8,759,350 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED
The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for OTSUKA PHARMACEUTICAL CO., LTD. v. TORRENT PHARMACEUTICALS LIMITED (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 127 | Opinion | various patents covering Otsuka’s Abilify® aripiprazole product, U.S. Patent Nos. 8,017,615 (“the ’…primary compound patent for Abilify, U.S. Patent No. 5,006,528 (hereinafter, the “’528 Patent”), and because… ’615 patent”) and 8,580,796 (“the ’796 patent”). Otsuka now moves to dismiss Torrent’s Fifth…for trial the patent issues raised in this litigation from the antitrust and/or patent misuse issues… 355(j), Otsuka identifies the ’615 patent and the ’796 patent, both of which Otsuka owns by virtue | External link to document |
| 2015-09-25 | 152 | Memorandum | include: U.S. Patent Nos. 5,006,528 (“the ’528 patent”), 7,053,092 (“the ’092 patent”), 8,017,615 (… (“the ’615 patent”), 8,580,796 (“the ’796 patent”), 8,642,600 (“the ’600 patent”), 8,642,760 (“the…the ’760 patent”), and 8,759,350 (“the ’350 patent,” and collectively, the “patents-in-suit”). …various patents covering Otsuka’s brand name aripiprazole product, Abilify®. 1 1 The patents asserted…Local Patent Rules, the Court explains at the outset the overall structure of the Local Patent Rules | External link to document |
| 2015-11-15 | 166 | Opinion | 5,006,528 (“the ’528 patent”), 7,053,092 (“the ’092 patent”), 8,017,615 (“the ’615 patent”), 8,580,796 (“…(“the ’796 patent”), 8,642,600 (“the ’600 patent”), 8,642,760 (“the ’760 patent”), and 8,759,350…identifies the ’528 Patent, the primary aripiprazole compound patent, as well the ’600 Patent, which claims…The ’350 Patent: Otsuka’s Asserted Method of Use Patent The ’350 Patent, by contrast…specifications: 23 (See ’615 Patent at 9:36-63; ’760 Patent at 9:37-63; ’796 Patent at 9:34-60.) 23Although | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
